Bayer's MRI contrast agent gets FDA approval for use in cardiac disease

Singapore News News

Bayer's MRI contrast agent gets FDA approval for use in cardiac disease
Singapore Latest News,Singapore Headlines
  • 📰 ChannelNewsAsia
  • ⏱ Reading Time:
  • 35 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 17%
  • Publisher: 66%

REUTERS: Bayer AG on Monday said U.S. regulators approved its contrast agent for use in magnetic resonance imaging (MRI) to assess patients with ...

REUTERS: Bayer AG on Monday said U.S. regulators approved its contrast agent for use in magnetic resonance imaging to assess patients with known or suspected coronary artery disease.

The injection, Gadavist, is an approved agent for use in MRI of the central nervous system and breasts. Contrast agents are used to make MRI scans easier to see.Gadavist is the only contrast agent approved by the U.S. Food and Drug Administration for use in cardiac MR, an important diagnostic tool for patients with coronary artery disease , Bayer said.

The approval was based on two multinational late-stage studies of nearly 1,000 adults with suspected or known CAD based on signs and symptoms. CAD develops when the major blood vessels that supply the heart with blood, oxygen and nutrients become damaged or diseased and affects about 16.5 million Americans, the company said.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

ChannelNewsAsia /  🏆 6. in SG

Singapore Latest News, Singapore Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

AstraZeneca's Farxiga fails to get US approval for Type-1 diabetesAstraZeneca's Farxiga fails to get US approval for Type-1 diabetesBritish drugmaker AstraZeneca Plc said on Monday the U.S. Food and Drug Administration declined to approve its diabetes treatment, Farxiga, for ...
Read more »

One in five NUS medical students gets financial helpOne in five NUS medical students gets financial helpThe National University of Singapore's (NUS) medical degree course is the most competitive course to get into. It is also the most expensive - charging almost $29,000 in tuition fees a year. So one would expect a large number of students entering the school to come from fairly affluent families who can afford to pay the high fees.. Read more at straitstimes.com.
Read more »



Render Time: 2025-04-08 11:50:11